0 Commentaires
0 Parts
519 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Animal Biotechnology Market: Competitive Landscape and Industry InsightsThe global animal biotechnology market was valued at USD 24,439.01 million in 2022 and is projected to reach USD 56,949.40 million by 2032, expanding at a CAGR of 8.8% from 2023 to 2032. These findings come from the latest Polaris Market Research study, Animal Biotechnology Market , which evaluates the factors shaping demand, the segments and regions expected to contribute most to growth, and...0 Commentaires 0 Parts 453 Vue 0 Aperçu
-
Europe CRISPR & Cas Genes Market: Biotechnology Advancements and Industry TrendsThe Europe CRISPR & Cas Genes Market is expanding rapidly, supported by strong government and EU research funding and a growing biotechnology and pharmaceutical industry. Valued at USD 1.35 billion in 2024, the market is projected to reach USD 1.59 billion in 2025 and USD 7.25 billion by 2034, growing at a CAGR of 18.4% during the forecast period 2025–2034. CRISPR-Cas is a natural...0 Commentaires 0 Parts 162 Vue 0 Aperçu
-
Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in EuropeAlvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...0 Commentaires 0 Parts 765 Vue 0 Aperçu
-
Danaher (DHR) raised its 2026 profit outlook as core sales grew only 3.0%Adjusted earnings per share rose 11.5% in the third quarter while core sales grew 3.0%, and the full-year range moved up by less than the quarter's gain. Cash flow and segment mix tell a narrower story. Danaher Corporation (DHR) reported third-quarter 2026 results on October 21 and raised its full-year adjusted earnings guidance. Adjusted diluted earnings per share reached $2.11, up from $1.89...0 Commentaires 0 Parts 475 Vue 0 Aperçu
-
Exosomes Market to Reach USD 912.33 Million by 2033, Growing at 14.7% CAGRThe global exosomes market size was valued at USD 265.51 million in 2024 and is anticipated to grow from USD 304.54 million in 2025 to reach USD 912.33 million in 2033, growing at a CAGR of 14.7% during the forecast period (2025–2033). According to Straits Research, this report provides a clear understanding of the Exosomes Market by analyzing its overall structure, key...0 Commentaires 0 Parts 4KB Vue 0 Aperçu
-
Global Biomarkers Market to Surge to USD 267.23 Billion by 2033, Driven by Advances in Precision MedicineThe global biomarkers market size was valued at USD 89.81 billion in 2024 and is expected to grow from USD 101.38 billion in 2025 to reach USD 267.23 billion in 2033, growing at a CAGR of 12.88% during the forecast period (2025–2033). How Is the Biomarkers Market Analyzed and What Research Methodology Is Used? The study examines the Biomarkers...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Global Exosome Manufacturing Services Market: Technologies, Services and Business Opportunities"According to the latest report published by Data Bridge Market Research, the Exosome Manufacturing Services Market CAGR ValueAs per Data Bridge Market Research analysis The Exosome Manufacturing Services Market was valued at USD 964.00 million in 2025 and is projected to reach USD 3,478.73 million by 2033, growing at a CAGR of 17.40% from 2026 to 2033. Market insights provided...0 Commentaires 0 Parts 832 Vue 0 Aperçu
-
Plasma Fractionation Market: Advanced Fractionation Technologies & Industry TrendsPlasma Fractionation Market: Growth, Trends, Demand & Forecast to 2033 Plasma Fractionation Market Overview The global Plasma Fractionation Market is witnessing steady expansion as demand for plasma-derived therapies continues to increase across healthcare systems. The market was valued at approximately USD 34.4 billion in 2025 and is projected to reach USD...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Single-Use Bioprocessing Probes & Sensors Market GrowthAccording to the latest report published by Data Bridge Market Research, the Single-Use Bioprocessing Probes and Sensors Market CAGR Value The global single-use bioprocessing probes and sensors market size was valued at USD 3.54 billion in 2024 and is expected to reach USD 9.55 billion by 2032, at a CAGR of 13.2% during the forecast period.This Single-Use Bioprocessing Probes and...0 Commentaires 0 Parts 66 Vue 0 Aperçu
-
Sports Medicine Biologics Market: Advances in Orthopedic Injury ManagementSports Medicine Biologics Market: Growth, Trends, and Forecast to 2034 Overview The global Sports Medicine Biologics Market was valued at USD 2.04 billion in 2026 and is projected to reach USD 3.09 billion by 2034, expanding at a CAGR of 5.6% during the forecast period. Market growth is supported by rising sports-related injuries, increasing participation in physical activities, and growing...0 Commentaires 0 Parts 146 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek